Alcon (ALC)
(Delayed Data from NYSE)
$96.65 USD
-0.51 (-0.52%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $96.64 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Earnings News For ALC
-
Alcon (ALC) Q2 Earnings Meet Estimates, Revenues Increase Y/Y
-
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
-
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
-
Algoma Central Corporation Reports Financial Results for the 2024 Second Quarter
-
Alcon (ALC) Rides on Innovation, Balanced Segmental Sales
-
Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand
-
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
-
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
-
Algoma Central Corporation Reports Financial Results for the 2024 First Quarter
-
Alcon (ALC) Q4 Earnings Beat Estimates, Margins Expand
-
Algoma Central Corporation Reports Financial Results for Fiscal 2023
-
Algoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024
-
Alcon (ALC) Q3 Earnings Miss Estimates, Margins Increase
-
Alcon Reports Third Quarter 2023 Results
-
Alcon Reports Third Quarter 2023 Results
-
Algoma Central Corporation Reports Financial Performance for the 2023 Third Quarter
-
Alcon (ALC) Q2 Earnings Surpass Estimates, Margins Increase
-
Alcon Reports Second Quarter 2023 Results
-
Alcon Reports Second Quarter 2023 Results
-
Alcon (ALC) to Report Q2 Earnings: What's in the Cards?
-
Algoma Central Corporation Reports Financial Performance for the 2023 Second Quarter
-
Alcon (ALC) Q1 Earnings Surpass Estimates, 23' EPS View Up
-
Alcon Reports First Quarter 2023 Results
-
Alcon Reports First Quarter 2023 Results
-
Algoma Central Corporation Reports Financial Performance for the 2023 First Quarter